VEGFA and blindness (disorder): Since the approval of anti-vascular endothelial growth factor (anti-VEGF) pharmacotherapy in 2006, the prevalence of legal blindness and visual impairment caused by nAMD has been considerably reduced, removing nAMD from the list of incurable diseases.3